Most patients do well on topical therapy, but innovation in IOP-lowering drops remains essential. One might ask why topical eye drop medications remain the mainstay of glaucoma therapy in the US and ...

Please provide your email address to receive an email when new articles are posted on . Patient adherence to topical glaucoma treatment remains an obstacle, with poorer adherence seen as patients are ...